Skip to main content

Concerns, Healthcare Use, and Treatment Interruptions in Patients With Common Autoimmune Rheumatic Diseases During the COVID-19 Pandemic

This study explores concerns and behaviors of patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and systemic lupus erythematosus (SLE) during the early months of the COVID-19 pandemic. Through a survey conducted within the ArthritisPower registry, it was found that patients with autoimmune rheumatic disease frequently avoided office visits, laboratory testing and experienced DMARD interruptions that were not recommended by a physician. Concerns and behaviors were compared among patients with different conditions, disease-modifying antirheumatic drug (DMARD) use, geographic measures of urban status, income, education, and COVID-19 activity.


Click here to read more

Click to read more